AI’s next frontier: The future of brain-computer interfaces for good

In personWorkshop
  • Date
    31 May 2024
    Timeframe
    15:00 - 18:00 CEST Geneva
    Duration
    180 minutes
    Share this session

    Context

    This panel brings together leading experts in the field of brain-computer interfaces (BCIs) to discuss the latest advancements, ethical implications, and future directions of neurotechnology. This is a crucial conversation at the intersection of neuroscience, technology, and societal impact.

    Objective

    To explore the role of neurotechnology in enhancing AI safety, address societal risks such as privacy and equality, and discuss the metrics and incentives for responsible development and commercialization.

    At the intersection of technology and human intelligence lies Brain-machine interfaces (BMIs). These technologies have the possibility of advancing our understanding of the brain, enable novel medical treatments and redefine human-machine interaction. At the same time, concerns have been raised about their effect on privacy, autonomy, and the future of human identity in an increasingly digital world.

     

    This workshop gathers leading figures in neuroscience and AI who will share the latest advancements in BMI, their envisioned impact, and current discussions on BMI governance and regulation. As we stand on the cusp of a new era in neurotechnology, this workshop offers a unique opportunity to engage with the minds at the forefront of AI and BMI, identify effective ways to steer the advancement of the field, and envision a future where technology and human intelligence converge for the greater good.

  • Neurologist
    ,
    Massachusetts General Hospital
    Dr. Rubin is a critical care neurologist at Massachusetts General Hospital and Instructor of Neurology at Harvard Medical School. As a faculty member of the Center for Neurotechnology and Neurorecovery, he conducts research focused on the application of computational neuroscientific principals to clinical problems encountered in clinical neurology to drive the development of novel tools and technologies to improve the outcomes of patients with neurologic injury. Dr. Rubin received his B.S. from Cornell University and his M.D./Ph.D. from Columbia University College of Physicians and Surgeons. He completed an internship in internal medicine at Brigham and Women's Hospital and neurology residency and neurocritical care fellowship at Massachusetts General Hospital and Brigham and Women's Hospital.
    Member of the UN Human Rights Council Advisory Committee
    ,
    United Nations
    <span data-contrast="auto">Milena Costas Trascasas is the Chair of the UN Human Rights Council’s Advisory Committee and the rapporteur of the study on human rights and neurotechnology which will be submitted to the Human Rights Council in September 2024. (https://www.ohchr.org/en/hr-bodies/hrc/advisory-committee/neurotechnologies-and-human-rights) </span><span data-ccp-props="{"201341983":0,"335551550":6,"335551620":6,"335559739":160,"335559740":259}"> </span> <span data-ccp-props="{"201341983":0,"335551550":6,"335551620":6,"335559739":160,"335559740":259}"> </span> <span data-contrast="auto">Holding a PhD in public international law from the University Complutense of Madrid, she is specialized in human rights and international humanitarian law. She has carried out research, published and taught in several universities and academic institutions in Spain, Italy, and Switzerland. Milena currently works as independent expert and legal adviser for international organizations, governments, and non-governmental organisations.</span><span data-ccp-props="{"201341983":0,"335551550":6,"335551620":6,"335559739":160,"335559740":259}"> </span>
    Award-winning artist, storyteller and strategist
    <div dir="ltr"> <div> <div id="x_mail-editor-reference-message-container"> <div> <div> <p>Taryn Southern is an award-winning storyteller, AI strategist and artist at the intersection of AI and human potential. As a pioneering content creator, she amassed more than 1 billion views on her content before achieving a number of other firsts, including composing <a title="Original URL: https://www.tarynsouthern.com/album. Click or tap if you trust this link." href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.tarynsouthern.com%2Falbum&data=05%7C02%7Celanthi.lumani%40itu.int%7Cdf53f52b8c4c4f94399608dc783dd6af%7C23e464d704e64b87913c24bd89219fd3%7C0%7C0%7C638517454198988633%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=EAL1cTc%2FOGf77McYK11EG7uMyBEWT5sYYTa%2F2dQRYbM%3D&reserved=0" target="_blank" rel="noopener noreferrer" data-auth="Verified" data-linkindex="1">the world’s first AI pop album</a> and directing a Tribeca Film <a title="Original URL: http://www.iamhumanfilm.com/. Click or tap if you trust this link." href="https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.iamhumanfilm.com%2F&data=05%7C02%7Celanthi.lumani%40itu.int%7Cdf53f52b8c4c4f94399608dc783dd6af%7C23e464d704e64b87913c24bd89219fd3%7C0%7C0%7C638517454198999902%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=%2FO%2FHsOoLnYqlBl9CDHQ3vrgCWyo9HBp0q9pK6YV2sOA%3D&reserved=0" target="_blank" rel="noopener noreferrer" data-auth="Verified" data-linkindex="2">documentary</a> on brain-computer interfaces. As a breast cancer survivor and head of special projects at Blackrock Neurotech, Taryn is passionate about the application of technology to restore function and bring independence to patients. As a speaker and artist, she has been invited to present at companies like Google, Dell, Gartner, Lenovo, Morgan Stanley and Deloitte on how to harness the creative powers of AI. Her work has been featured in Fast Company, Wired, Forbes, Psychology Today, Harvard Business Review, Vanity Fair, Billboard, and more. </p> </div> </div> </div> </div> </div>
    Research Staff Member
    ,
    IBM T.J. Watson Research Lab
    <span class="TextRun SCXW97252851 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW97252851 BCX0">Sara Berger is a Research Staff Member at IBM Research. Sara received her PhD in systems and cognitive neuroscience from Northwestern University, with an emphasis on chronic pain conditions, clinical psychology, and bioethics. In the past, she has focused on identifying, quantifying, treating, and predicting changes in acute and chronic pain in animals and humans using machine learning, neurotechnology, and other methods - with over a decade of experience in the field of pain. Sara’s knowledge and skills also span clinical trial management and design, critical disability studies, and NLP. At IBM, she has applied her knowledge of neuroimaging, psychology, and behavioral research to address a wide variety of questions and applications. She is currently leveraging her multidisciplinary interests and background to design frameworks, tools, and methods that aid researchers and practitioners in being more proactively responsible in their projects and products, including in the field of neurotechnology. In 2021, Sara was named one of MIT Tech Review's 35 Innovators and Visionaries under 35.</span></span><span class="EOP SCXW97252851 BCX0" data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span>
    Head of the Institute of Neural Engineering
    ,
    Graz University of Technology
    Prof. Dr. Gernot Müller-Putz is head of the Institute of Neural Engineering and its associated Laboratory of Brain-Computer Interfaces. He received his MSc in electrical and biomedical engineering, his PhD in electrical engineering and his habilitation and “venia docendi” in medical informatics from Graz University of Technoloy. Since 2014 he is full professor for semantic data analysis. He interested in brain-computer interface research based on EEG and ECoG, mainly for movement restoration and re-establishing of communication. He has also managed numerouse international projects, mainly funded by EU. Furthermore, he organized and hosted the Graz Brain-Computer Interface Conference over the last two decades in Graz, the next one in preparation for 2024. In 2015, he was awarded with an ERC Consolidator Grant “Feel your Reach” from the European Research Council. In 2017 he received the Ludwig-Guttman Award from the German Medical Spinal Cord Injury Association (DMGP). He is currently member of the Board of Directors of the International Brain-Computer Interface Society, and he is founding member and scientific Co-Director of the NeuroIS Society. Since October 2023, he is Dean of the department for Computer Science and Biomedical Engineering at TU Graz.
    Professor
    ,
    University of Texas at Austin
    <span lang="en-US">Dr. José del R. Millán is a professor and holds the Carol Cockrell Curran Chair in the Chandra Family Department of Electrical and Computer Engineering at The University of Texas at Austin. He is also a professor in the Department of Neurology at Dell Medical School, professor (by Courtesy) in the Department of Biomedical Engineering, faculty of the Mulva Clinic for the Neurosciences, and member of the Institute for Neuroscience. He is co-director of the UT CARE Initiative and associate director of Texas Robotics.<br aria-hidden="true" /><br aria-hidden="true" /></span>Dr. Millán received a PhD in computer science from the Technical University of Catalonia, Barcelona, in 1992. Prior to joining UT Austin, he was a research scientist at the Joint Research Centre of the European Commission in Ispra (Italy) and a senior researcher at the Idiap Research Institute in Martigny (Switzerland). Most recently, he was Defitech Foundation Chair in Brain-Machine Interface at the École Polytechnique Fédérale de Lausanne in Switzerland (EPFL).<br aria-hidden="true" /><br aria-hidden="true" />Dr. Millán has made several seminal contributions to the field of brain-machine interfaces (BMI), especially based on electroencephalogram signals. Most of his achievements revolve around the design of brain-controlled robots. He has received several recognitions for these seminal and pioneering achievements, notably the IEEE-SMC Nobert Wiener Award in 2011, elevation to IEEE Fellow in 2017, and elected Fellow of the International Academy of Medical and Biological Engineering in 2020. In addition to his work on the fundamentals of BMI and design of neuroprosthetics, Dr. Millán is prioritizing the translation of BMI to people who live with motor and cognitive disabilities.
    Group Leader Responsible AI Innovation
    ,
    Zürich University of Applied Sciences
    <span class="TextRun SCXW155838274 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW155838274 BCX8">Ricardo Chavarriaga is a researcher and public speaker in </span><span class="NormalTextRun SpellingErrorV2Themed SCXW155838274 BCX8">neurotechnologies</span><span class="NormalTextRun SCXW155838274 BCX8">, artificial intelligence, and responsible innovation. Dr Chavarriaga leads the Responsible AI Innovation group at </span><span class="NormalTextRun SpellingErrorV2Themed SCXW155838274 BCX8">at</span><span class="NormalTextRun SCXW155838274 BCX8"> the Center for Artificial Intelligence of the Zürich University of Applied Sciences (</span></span><a class="Hyperlink SCXW155838274 BCX8" href="https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.zhaw.ch%2Finit&data=05%7C01%7Cguillem.martinez-roura%40itu.int%7C44a467917766439228fb08dbae31ab71%7C23e464d704e64b87913c24bd89219fd3%7C0%7C0%7C638295300646618133%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=wzKbLOAY%2Bg3gnEIXir76mMEu8VgLHy9jXhp409AR%2F4g%3D&reserved=0" target="_blank" rel="noreferrer noopener"><span class="TextRun Underlined SCXW155838274 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW155838274 BCX8" data-ccp-charstyle="Hyperlink">ZHAW</span></span></a><span class="TextRun SCXW155838274 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW155838274 BCX8">) and is the head of the Swiss office of the Confederation of Laboratories for AI Research in Europe (</span></span><a class="Hyperlink SCXW155838274 BCX8" href="https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Fclaire-ai.org%2F&data=05%7C01%7Cguillem.martinez-roura%40itu.int%7C44a467917766439228fb08dbae31ab71%7C23e464d704e64b87913c24bd89219fd3%7C0%7C0%7C638295300646618133%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=N%2BljWm5Qo6oTqLOBGjhfED10fBTRqQ7cOG1y34xqowI%3D&reserved=0" target="_blank" rel="noreferrer noopener"><span class="TextRun Underlined SCXW155838274 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW155838274 BCX8" data-ccp-charstyle="Hyperlink">CLAIRE</span></span></a><span class="TextRun SCXW155838274 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW155838274 BCX8">). His work is focused on leveraging neuroscience, AI, and ethics for advancing responsible innovation and governance of human-centered </span><span class="NormalTextRun SCXW155838274 BCX8">technology</span></span><span class="EOP SCXW155838274 BCX8" data-ccp-props="{"134233117":false,"134233118":false,"201341983":0,"335551550":6,"335551620":6,"335559738":0,"335559739":0,"335559740":259}"> </span>
    Co-Founder and CEO
    ,
    Forest Neurotech
    <span lang="en-US">Dr. Sumner L. Norman is a pioneering figure at the nexus of neuroscience, engineering, and impact-driven entrepreneurship. His research in brain-machine interfaces (BMIs) is forging new paths in neurotechnology to transform the lives of those with neurological injuries and diseases. Sumner co-founded </span><a title="Original URL: https://forestneurotech.org/. Click or tap if you trust this link." href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fforestneurotech.org%2F&data=05%7C02%7CRae.Paladin%40itu.int%7C220aa08b18b74832827608dc1da5ee6d%7C23e464d704e64b87913c24bd89219fd3%7C0%7C0%7C638417845712357229%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=fGRD%2FRtuUcVqwvlqR51rLyauIquw7mwjAlaBQudqbHI%3D&reserved=0" target="_blank" rel="noopener noreferrer" data-auth="Verified" data-linkindex="0"><span lang="en-US">Forest Neurotech</span></a><span lang="en-US">, a nonprofit </span><a title="Original URL: https://www.convergentresearch.org/about-fros. Click or tap if you trust this link." href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.convergentresearch.org%2Fabout-fros&data=05%7C02%7CRae.Paladin%40itu.int%7C220aa08b18b74832827608dc1da5ee6d%7C23e464d704e64b87913c24bd89219fd3%7C0%7C0%7C638417845712368109%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=DGPOJOjU9jWULxBj58jj6WymQpieniRF5S93M2aHBY0%3D&reserved=0" target="_blank" rel="noopener noreferrer" data-auth="Verified" data-linkindex="1"><span lang="en-US">focused research organization</span></a><span lang="en-US"> that is ushering in a new generation of neurotechnology. Forest was founded on the principles of Sumner’s research at Caltech, where he pioneered ultrasound-based BCIs – a high-performance technique that offers a minimally invasive approach to monitoring and stimulating brain-wide function. In addition to research, Sumner has been active in state and federal government advocacy for scientific research, education, and innovation.</span>
    Inaugural Professor of Artificial Intelligence Ethics and Neuroscience and the Deputy Director
    ,
    Center for Ethics and History of Medicine at the Medical School of the Technical University of Munich (TUM)
    Marcello Ienca is the inaugural Professor of Artificial Intelligence Ethics and Neuroscience and the Deputy Director of the Center for Ethics and History of Medicine at the Medical School of the Technical University of Munich (TUM). He is also the Head of the Intelligent Systems Group at the Swiss Federal Institute of Technology in Lausanne (EPFL). His research spans a broad interdisciplinary terrain but focuses primarily on the science and ethics of intelligent systems of both biological and artificial nature. In addition, Ienca works actively in science and technology policy, serving as a commissioned expert or rapporteur for organizations such as the OECD, the Council of Europe, the UN and the EU Parliament. His articles have been published in journals such as Nature Medicine, Nature Biotechnology, Nature Machine Intelligence and covered by media outlets such as The New Yorker, The Times, The Guardian, BBC etc. Ienca is a board member of the International Neuroethics Society and the Neuroethics Lead of the International Brain Initiative.
    Co-founder
    ,
    Neuroelectrics
    <span data-contrast="auto">Ana Maiques is a prominent business and innovation figure, whose impact and influence in the fields of entrepreneurship and neuroscience are undeniable. As a co-founder of Neuroelectrics, a company with a bold vision to transform our interaction with the brain through the development of pioneering technologies to monitor and stimulate this vital organ, she has demonstrated exceptional leadership and inspiration.</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span> <span data-contrast="auto">Under her leadership at Neuroelectrics, the company has achieved remarkable accomplishments, including recognition as one of the Best Entrepreneurial Companies in 2016 in the United States, awarded by Entrepreneur magazine. Her impressive career has been acknowledged on multiple occasions, including the prestigious Most Exceptional Entrepreneurs award by Goldman Sachs at the 2022 Builders and Innovators Summit, as well as the distinguished European Union Prize for Women Innovators from the European Commission in 2014, and the title of Most Inspiring Women on the Inspiring Fifty list in Europe for two consecutive years in 2015 and 2016.</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span> <span data-contrast="auto">In addition to her significant role at Neuroelectrics, Ana Maiques is an active figure in the innovation scene, both in Europe and the United States. She is a permanent member of the European Innovation Council Advisory Board and became a Termeer Fellow at the Henri Termeer Foundation in 2018, reflecting her commitment to scientific and technological advancement</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span> <span data-contrast="auto">Equally important is her role as a co-founder of EsTech, a platform for Spanish scale-ups and unicorns dedicated to fostering the growth of innovative companies. Her vision and leadership are fundamental to the realization of this ambitious mission.</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span> <span data-contrast="auto"> </span><span data-contrast="auto">Undoubtedly, Ana Maiques is a passionate advocate for gender equality in STEM fields. Her commitment extends beyond business and into creating opportunities for more women to participate in these fields. Through her dedication to Neuroelectrics, she has demonstrated that business success and the promotion of scientific advancements can go hand in hand. Ana is dedicated to business ethics and remains determined to break down barriers and promote a brighter future in science and technology.</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span>
    CEO
    ,
    Institute of Neuroethics
    <span lang="EN-US">Dr. Karen S. Rommelfanger is a neurotech ethicist and strategist. She is founder and director of the </span><span lang="EN-US"><a href="https://instituteofneuroethics.org/">Institute of Neuroethics</a></span><span lang="EN-US">, the first think tank wholly dedicated to neuroethics. Her lab, the </span><span lang="EN-US"><a href="https://neuroethicslab.com/">Neuroethics and Neurotech Innovation Collaboratory</a></span><span lang="EN-US"> explores how evolving neuroscience challenges societal definitions of disease and wellness, cross-cultural neuroethics, and cross-sectoral neuroethics policy. Her boutique consultancy </span><span lang="EN-US"><a href="https://ningenstrategy.com/">Ningen Neuroethics Co-Lab</a></span><span lang="EN-US"> works specifically on applied neuroethics and strategy. Dr. Rommelfanger maintains a professorship in Emory University’s Departments of Neurology and Psychiatry and Behavioral Sciences. She received her PhD in neuroscience and postdoctoral training in neuroscience, neural engineering, and neuroethics. Her scholarship has been published in high impact journals such as <i>Nature</i>, <i>Neuron</i>, and <i>PNAS</i> and she co-edited the <i>Routledge Handbook of Neuroethics</i>. She serves as the first neuroethicist editor at<i> Neuron</i>, served as senior editor of the American Journal of Bioethics Neuroscience and executive board member of the International Neuroethics Society. In recognition of her neuroethics stewardship in the neuroscience community, she was appointed to the National Institute of Health (NIH) </span><span lang="EN-US"><a href="https://braininitiative.nih.gov/about/neuroethics-working-group">BRAIN Initiative Neuroethics</a></span><span lang="EN-US"> Working Group and DARPA’s ELSI Neurotechnology Panel. She has consulted for the OECD’s implementation guidance for the first international </span><span lang="EN-US"><a href="https://www.oecd.org/science/recommendation-on-responsible-innovation-in-neurotechnology.htm">standard in responsible innovation for neurotechnology</a></span><span lang="EN-US"> and served as </span><span lang="EN-US"><a href="https://rm.coe.int/round-table-report-en/1680a969ed">rapporteur for the Council of Europe</a></span><span lang="EN-US"> to assess proposal for novel neurorights. Dedicated to cross-cultural work in neuroethics, she co-chaired of the Global Neuroethics Workgroup of the </span><span lang="EN-US"><a href="https://www.internationalbraininitiative.org/">International Brain Initiative</a></span><span lang="EN-US">, a consortium of large-scale national-level brain research projects and served on the World Economic Forum’s Global Futures Council. She is a frequent contributor and commentator in national and international media on neuroethics strategy, neurotech innovation, and policy.</span><span lang="EN-US"> </span> <span lang="EN-US"> </span> <span lang="EN-US">NNIC: </span><span lang="EN-US"><a href="https://neuroethicslab.com/">https://neuroethicslab.com</a></span><span lang="EN-US"> </span> <span lang="EN-US">IoNx:  </span><span lang="EN-US"><a href="https://instituteofneuroethics.org/">https://instituteofneuroethics.org</a></span><span lang="EN-US">  </span> <span lang="EN-US">Ningen: </span><span lang="EN-US"><a href="https://ningenstrategy.com/">https://ningenstrategy.com</a></span><span lang="EN-US">  </span>
    CEO
    ,
    Wyss Center
      <span lang="en-US">Prof. Dr. med. Erwin Böttinger joined the Wyss Center as Chief Executive Officer (CEO) in April 2023.</span>   <span lang="en-US">Erwin has a longstanding track record in personalized medicine, with emphasis on genomics and digital technologies. Before joining the Wyss Center, he was instrumental in building the Charles Bronfman Institute for Personalized Medicine and the Hasso Plattner Institute for Digital Health at Mount Sinai, at the Icahn School of Medicine at Mount Sinai in New York City, both with a strong translational focus. He was also the principal architect of the Mount Sinai’s BioMe™ Biobank.</span>   <span lang="en-US">Erwin served as founding director of the Digital Health Center at the Hasso Plattner Institute for Digital Engineering and University Potsdam, and as CEO of the Berlin Institute of Health, Berlin, Germany, where he was responsible for BIH’s forward-looking strategy 'Personalized Medicine - Advanced Therapies'. </span>
    CEO & Research Director
    ,
    Intheon
    Dr. Tim Mullen is a neuroscientist and entrepreneur with nearly two decades of service at the forefront of neuroscience innovation. His scientific research has contributed to understanding the computational role of brain network dynamics in cognition, brain health, and conscious experience, and in pioneering the use of brain-computer interfaces (BCI) in everyday life. Additionally, he has been a key contributor in developing and disseminating widely utilized open-source projects for neuroscientific discovery, such as EEGLAB, LSL, and SIFT, and in shaping emerging IEEE and ANSI neurotechnology standards.   Dr. Mullen is a founder of several pioneering neurotechnology companies, including Intheon, creator of the first platform for “anytime, anywhere” BCI and neurodata analytics, and Sanmai, developing innovative non-invasive mental health treatments using focused ultrasound. He actively advises organizations across industry, investment, and government sectors. Additionally, he contributes to shaping ethical standards and practices in neurotechnology and is a member of the BrainMind-OECD Neuroethics Advisory Committee.   As a lifelong musician and a new media artist, Tim Mullen engages in creative endeavors that bridge emerging technology and art and blur boundaries between mental and physical worlds. His interactive installations and performances, exhibited over the past two decades in North America and Europe, have explored themes of interpersonal resonance, emotional communication, ecopsychology and nature connectedness, causality and emergence in complex systems, and the concept of “audience as performer.” He is a Board Member with leading classical arts non-profit Mainly Mozart in San Diego and the founding director of its annual festival, "Mozart & the Mind," which explores the impact of music on our brains, health, and lives.   Dr. Mullen is an alumnus of UC Berkeley and UC San Diego, where he was a Glushko, San Diego, and Swartz Fellow and recipient of the UCSD Chancellor’s Dissertation Medal for outstanding doctoral research.
    Share this session
    Discover more from programme stream

    Are you sure you want to remove this speaker?